Avego Bioscience Capital, L.P. — Form D/A
Avego Bioscience Capital, L.P. of ALPHARETTA, GA, a pooled investment fund, filed a Form D amendment with the SEC on 2023-03-09. $49.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-03-09
- Form: D/A
- Accession: 0000919574-23-002093
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $49.9M
- Investors: 19
- Date of first sale: 2021-01-12
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-437251
Issuer
- Name: Avego Bioscience Capital, L.P.
- CIK: 0001910611
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 100 NORTH MAIN ST, ALPHARETTA, GA, 30009
- Phone: 646-844-0030
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| -- Avego Management, LLC | Executive Officer | Alpharetta, GA |
| -- Avego Management, LLC | Promoter | Alpharetta, GA |
| -- Velan Capital Invesment Management LP | Executive Officer | Alpharetta, GA |
| -- Velan Capital Invesment Management LP | Promoter | Alpharetta, GA |
| -- Avego Bioscience Capital GP, LLC | Executive Officer | Alpharetta, GA |
| -- Avego Bioscience Capital GP, LLC | Promoter | Alpharetta, GA |
Other filings by this issuer (3)
More